» Articles » PMID: 26409279

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

Abstract

Childhood tuberculosis contributes significantly to the global tuberculosis disease burden but remains challenging to diagnose due to inadequate methods of pathogen detection in paucibacillary pediatric samples and lack of a child-specific host biomarker to identify disease. Accurately diagnosing tuberculosis in children is required to improve case detection, surveillance, healthcare delivery, and effective advocacy. In May 2014, the National Institutes of Health convened a workshop including researchers in the field to delineate priorities to address this research gap. This blueprint describes the consensus from the workshop, identifies critical research steps to advance this field, and aims to catalyze efforts toward harmonization and collaboration in this area.

Citing Articles

Feasibility and utility of a combined nasogastric-tube-and-string-test device for bacteriologic confirmation of pulmonary tuberculosis in young children.

Khambati N, Song R, Smith J, Bijker E, McCarthy K, Click E Diagn Microbiol Infect Dis. 2024; 109(3):116302.

PMID: 38657352 PMC: 11128341. DOI: 10.1016/j.diagmicrobio.2024.116302.


QuantiFERON Gold-In-Tube for the diagnosis of mycobacterial tuberculosis infection in children under 5 years of age: A systematic review and meta-analysis.

Volkman T, Muruganandah V, Graham H, Tosif S, Stokes S, Ranganathan S PLoS One. 2024; 19(1):e0295913.

PMID: 38166111 PMC: 10760833. DOI: 10.1371/journal.pone.0295913.


Host-Based Biomarkers in Saliva for the Diagnosis of Pulmonary Tuberculosis in Children: A Mini-Review.

Khambati N, Olbrich L, Ellner J, Salgame P, Song R, Bijker E Front Pediatr. 2021; 9:756043.

PMID: 34760853 PMC: 8575443. DOI: 10.3389/fped.2021.756043.


Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children.

Dutta N, Tornheim J, Fukutani K, Paradkar M, Tiburcio R, Kinikar A Sci Rep. 2020; 10(1):19527.

PMID: 33177551 PMC: 7658223. DOI: 10.1038/s41598-020-75513-8.


A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children.

Togun T, Hoggart C, Agbla S, Gomez M, Egere U, Sillah A EBioMedicine. 2020; 58:102909.

PMID: 32711253 PMC: 7381493. DOI: 10.1016/j.ebiom.2020.102909.


References
1.
Vaught J, Rogers J, Myers K, Lim M, Lockhart N, Moore H . An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr. 2011; 2011(42):1-7. DOI: 10.1093/jncimonographs/lgr006. View

2.
Graham S, Cuevas L, Jean-Philippe P, Browning R, Casenghi M, Detjen A . Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update. Clin Infect Dis. 2015; 61Suppl 3:S179-87. PMC: 4583568. DOI: 10.1093/cid/civ581. View

3.
Nahid P, Saukkonen J, Mac Kenzie W, Johnson J, Phillips P, Andersen J . CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med. 2011; 184(8):972-9. PMC: 3208659. DOI: 10.1164/rccm.201105-0827WS. View

4.
Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya E . Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis. 2012; 54(10):1388-96. DOI: 10.1093/cid/cis190. View

5.
Graham S, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M . Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis. 2012; 205 Suppl 2:S199-208. PMC: 3334506. DOI: 10.1093/infdis/jis008. View